Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEMEP: CHIP in Unprovoked Pulmonary Embolism
NCT04711746Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2021
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Variation of CHIP markers between patients groups at 2 years. Started Feb 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04711746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04711746.